Asset Details
MbrlCatalogueTitleDetail
Do you wish to reserve the book?
Effectiveness of a Mental Health Chatbot for People With Chronic Diseases: Randomized Controlled Trial
by
Luke, Alison
, Doucet, Shelley
, MacNeill, A Luke
in
Chatbots
/ Chronic illnesses
/ Generalized anxiety disorder
/ Mental depression
/ Original Paper
2024
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
You are currently in the queue to collect this book. You will be notified once it is your turn to collect the book.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Oops! Something went wrong.
While trying to remove the title from your shelf something went wrong :( Kindly try again later!
Do you wish to request the book?
Effectiveness of a Mental Health Chatbot for People With Chronic Diseases: Randomized Controlled Trial
by
Luke, Alison
, Doucet, Shelley
, MacNeill, A Luke
in
Chatbots
/ Chronic illnesses
/ Generalized anxiety disorder
/ Mental depression
/ Original Paper
2024
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Effectiveness of a Mental Health Chatbot for People With Chronic Diseases: Randomized Controlled Trial
Journal Article
Effectiveness of a Mental Health Chatbot for People With Chronic Diseases: Randomized Controlled Trial
2024
Request Book From Autostore
and Choose the Collection Method
Overview
People with chronic diseases tend to experience more mental health issues than their peers without these health conditions. Mental health chatbots offer a potential source of mental health support for people with chronic diseases.
The aim of this study was to determine whether a mental health chatbot can improve mental health in people with chronic diseases. We focused on 2 chronic diseases in particular: arthritis and diabetes.
Individuals with arthritis or diabetes were recruited using various web-based methods. Participants were randomly assigned to 1 of 2 groups. Those in the treatment group used a mental health chatbot app (Wysa [Wysa Inc]) over a period of 4 weeks. Those in the control group received no intervention. Participants completed measures of depression (Patient Health Questionnaire-9), anxiety (Generalized Anxiety Disorder Scale-7), and stress (Perceived Stress Scale-10) at baseline, with follow-up testing 2 and 4 weeks later. Participants in the treatment group completed feedback questions on their experiences with the app at the final assessment point.
A total of 68 participants (n=47, 69% women; mean age 42.87, SD 11.27 years) were included in the analysis. Participants were divided evenly between the treatment and control groups. Those in the treatment group reported decreases in depression (P<.001) and anxiety (P<.001) severity over the study period. No such changes were found among participants in the control group. No changes in stress were reported by participants in either group. Participants with arthritis reported higher levels of depression (P=.004) and anxiety (P=.004) severity than participants with diabetes over the course of the study, as well as higher levels of stress (P=.01); otherwise, patterns of results were similar across these health conditions. In response to the feedback questions, participants in the treatment group said that they liked many of the functions and features of the app, the general design of the app, and the user experience. They also disliked some aspects of the app, with most of these reports focusing on the chatbot's conversational abilities.
The results of this study suggest that mental health chatbots can be an effective source of mental health support for people with chronic diseases such as arthritis and diabetes. Although cost-effective and accessible, these programs have limitations and may not be well suited for all individuals.
ClinicalTrials.gov NCT04620668; https://www.clinicaltrials.gov/study/NCT04620668.
Publisher
JMIR Publications
This website uses cookies to ensure you get the best experience on our website.